Related Experiment Videos
Progress in the design of DNA sequence-specific lexitropsins
W L Walker1, M L Kopka, D S Goodsell
1Department of Biomathematics, University of California at Los Angeles 90095, USA.
Biopolymers
|January 1, 1997
Summary
Sequence-specific polyamides targeting DNA minor grooves show promise as drugs. Structure-based design advances linked polyamides for applications in cancer and infectious diseases, with strategies for genomic targeting.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Genomics
Background:
- Sequence-specific polyamides bind to the DNA minor groove.
- These compounds are investigated for therapeutic potential, including antibiotics and cancer treatments.
- Understanding DNA-polyamide interactions is crucial for drug development.
Purpose of the Study:
- To review the progress in structure-based design of minor-groove-binding polyamides.
- To discuss the evolution from early compounds like netropsin to current linked polyamides.
- To present theories and methods for achieving sequence specificity within complex genomes.
Main Methods:
- Review of existing literature on DNA-polyamide structures and binding.
- Analysis of structure-activity relationships in minor-groove binders.
- Exploration of computational and theoretical approaches for predicting DNA sequence recognition.
Main Results:
- Significant advancements in the structure-based design of polyamides.
- Development of effective linked polyamides with enhanced DNA binding properties.
- Establishment of theoretical frameworks for optimizing polyamide specificity against target DNA sequences.
Conclusions:
- Structure-based design has enabled the development of potent minor-groove-binding polyamides.
- Linked polyamides represent a promising class of molecules for therapeutic applications.
- Effective strategies exist for designing polyamides to target specific DNA sequences in the genome.